The entire CAR T-cell therapy process takes roughly five to seven weeks from the initial cell collection to the point where you’re cleared to go home. The actual infusion of modified cells is one of the shortest parts, often finished in under an hour. Most of the timeline is spent waiting for your cells to be engineered in a lab, recovering from side effects, and being monitored in a hospital setting.
The Full Timeline at a Glance
CAR T-cell therapy unfolds in distinct phases: cell collection, a manufacturing wait, conditioning chemotherapy, the infusion itself, and a monitoring period. Each phase has its own duration, and some overlap. Here’s how the weeks break down.
Cell Collection: Day One
The process starts with leukapheresis, a procedure where blood is drawn from one arm, passed through a machine that filters out white blood cells (including the T cells that will be modified), and returned through the other arm. This takes about four to six hours in a single session. It feels similar to donating blood, though it lasts considerably longer. Most people go home the same day.
Manufacturing: The Three-to-Four-Week Wait
Once collected, your T cells are shipped to a specialized lab where they’re genetically reprogrammed to recognize and attack cancer cells. This manufacturing step is the longest single phase, typically taking three to four weeks. During this time, your medical team monitors your cancer closely. If the disease is progressing, they may prescribe what’s called bridging therapy, a short course of chemotherapy designed to keep the cancer in check until your modified cells are ready. Not everyone needs bridging therapy.
Conditioning Chemotherapy: About One Week
A few days before infusion, you’ll receive lymphodepletion chemotherapy. This is a lighter regimen than traditional cancer chemotherapy, given over three to five consecutive days. Its purpose is to suppress your existing immune system so the new CAR T cells have room to multiply once they’re infused. After the final dose, there’s a required rest period of at least two days before the infusion to make sure the chemotherapy drugs have cleared enough that they won’t damage the incoming cells.
Infusion Day
The infusion itself is surprisingly quick. The modified T cells are delivered through an IV, and the process typically takes 30 minutes or less. It looks a lot like a blood transfusion. Most of infusion day is spent on pre-medications and monitoring rather than the infusion itself. You’ll stay in the hospital or visit the treatment center daily for close observation afterward.
Hospital Monitoring: Two to Four Weeks
This is where the most intensive part of recovery happens. After infusion, you’ll either remain in the hospital or stay nearby (within a short drive of the treatment center) for at least two to four weeks. The reason for this close watch is two potentially serious side effects that tend to appear in the first days.
Cytokine release syndrome (CRS) is the most common. It starts with a fever, usually within the first seven days after infusion, and happens because the CAR T cells trigger a massive immune response as they begin attacking cancer. Symptoms range from mild flu-like feelings to dangerously high fevers and drops in blood pressure. Most cases resolve within one to two weeks with treatment.
Neurotoxicity (sometimes called ICANS) can cause confusion, difficulty speaking, tremors, or headaches. It typically appears four to ten days after infusion and can overlap with CRS or follow it. The severity varies widely between patients, and symptoms are usually temporary, though they require careful management.
Recovery and Activity Restrictions
Even after you leave the hospital, recovery continues. Most treatment centers restrict driving for at least four weeks after infusion because of the risk of lingering neurological effects. A 2025 study looking at multiple myeloma patients found that universal driving restrictions beyond four weeks were unnecessary for most people, suggesting that the first month is the critical window.
Energy levels take longer to bounce back. Your immune system will be weakened for weeks to months after treatment, making you more vulnerable to infections. Many patients describe the first one to three months as a gradual return to normal, with fatigue being the most persistent issue. Regular blood work and clinic visits continue during this period to track your immune recovery and check the cancer’s response.
Long-Term Follow-Up: Years, Not Months
CAR T-cell therapy doesn’t end when you feel better. Because the treatment involves genetic modification of your cells, the FDA recommends long-term safety monitoring for up to 15 years. In practice, this means annual check-ups for the first five years, followed by yearly questionnaires or visits for an additional ten years. These follow-ups track for rare delayed complications, including secondary cancers. For most patients, these appointments become routine and brief, but they’re an important part of the overall commitment.
Total Time Commitment
Adding it all up: collection takes one day, manufacturing takes three to four weeks, conditioning takes about a week, and the post-infusion monitoring period adds another two to four weeks. From the day your cells are collected to the day you’re cleared to return home, expect roughly five to seven weeks. The broader recovery window stretches to about three months before most people feel close to their baseline, and the follow-up commitment extends for years. If you’re planning around work, travel, or caregiving, that initial five-to-seven-week block near the treatment center is the period that requires the most logistical preparation.